AU2002245333A1 - Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs - Google Patents

Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs

Info

Publication number
AU2002245333A1
AU2002245333A1 AU2002245333A AU2002245333A AU2002245333A1 AU 2002245333 A1 AU2002245333 A1 AU 2002245333A1 AU 2002245333 A AU2002245333 A AU 2002245333A AU 2002245333 A AU2002245333 A AU 2002245333A AU 2002245333 A1 AU2002245333 A1 AU 2002245333A1
Authority
AU
Australia
Prior art keywords
igfs
treatment
naturally occurring
growth factors
diabetic retinopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002245333A
Inventor
Douglas N. Ishii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colorado State University Research Foundation
Original Assignee
Colorado State University Research Foundation
Colorado State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colorado State University Research Foundation, Colorado State University filed Critical Colorado State University Research Foundation
Publication of AU2002245333A1 publication Critical patent/AU2002245333A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
AU2002245333A 2001-01-31 2002-01-29 Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs Abandoned AU2002245333A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26580301P 2001-01-31 2001-01-31
US60/265,803 2001-01-31
PCT/US2002/002443 WO2002060473A2 (en) 2001-01-31 2002-01-29 Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs

Publications (1)

Publication Number Publication Date
AU2002245333A1 true AU2002245333A1 (en) 2002-08-12

Family

ID=23011941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002245333A Abandoned AU2002245333A1 (en) 2001-01-31 2002-01-29 Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs

Country Status (2)

Country Link
AU (1) AU2002245333A1 (en)
WO (1) WO2002060473A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049014A1 (en) * 2003-11-18 2005-06-02 Pharmacia Corporation Cox-2 inhibitors for the treatment or prevention of diabetes-related ocular disorders
ITUB20169928A1 (en) * 2016-01-12 2017-07-12 Medical And Biotechnological Services In Sigla M B S Srl PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DIABETES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1570997A (en) * 1996-01-16 1997-08-11 Genentech Inc. Igf-i in combination with hypoglycemics for treatment of diabetes

Also Published As

Publication number Publication date
WO2002060473A2 (en) 2002-08-08
WO2002060473A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
WO2003059372A3 (en) Combined use of a glp-1 compound and a modulator of diabetic late complications
AU2001290688A1 (en) Apparatus and method for compensating for respiratory and patient motion during treatment
AU2002241228A1 (en) Method and composition for treatment of skeletal dysplasias
AUPR638101A0 (en) Composition and method for treatment of disease
AU2003224788A1 (en) Method for treatment of tissue
HUP0100928A3 (en) Methods for treatment of diabetes using peptide analogues of insulin
AU2002327430A1 (en) Methods for treating diabetes and other blood sugar disorders
AU2002322394A1 (en) Method for treating diabetes and obesity
AU2003295634A1 (en) Apparatus and method for palpograhic chacterization of vulnerable plaque and other biological tissue
AU2003211140A1 (en) Composition and method for inducing bone growth and healing
AU2002321587A1 (en) Treatment of substrates using an electrochemical method
AU2003294421A1 (en) Method for reducing or preventing modification of a polypeptide in solution
AU2000265109A1 (en) Method and compositions for prevention and/or treatment of diabetes and glucose modulation
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
IL161073A0 (en) Composition and method for treating diabetes
AU2003213985A1 (en) Method and composition for treating skin wounds with epidermal growth factor
AU2002245333A1 (en) Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs
AU1792901A (en) Methods for treating and preventing diabetic complications
AU2003285066A1 (en) Dosage forms containing stabilized choline and method for preparing same
AU2003288921A1 (en) Alpha 2hs glycoprotein for treatment of cancer and a method for preparation thereof
AU2002362181A1 (en) Arrangement and method for treatment of a pumpable substance
AU2003228787A1 (en) Composition and method for reducing post-prandial blood glucose
AU2003280320A1 (en) Human growth hormone treatment methods
AU2003214171A1 (en) Method for treating diabetic ulcers
HUP0203676A3 (en) Pharmaceutical composition and method for treatment of diabetes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase